[go: up one dir, main page]

ID30022A - Penggunaan senyawa-senyawa dari formula i untuk profilaksis dan terapi pada iskemia serebral - Google Patents

Penggunaan senyawa-senyawa dari formula i untuk profilaksis dan terapi pada iskemia serebral

Info

Publication number
ID30022A
ID30022A IDW00200101717A ID20011717A ID30022A ID 30022 A ID30022 A ID 30022A ID W00200101717 A IDW00200101717 A ID W00200101717A ID 20011717 A ID20011717 A ID 20011717A ID 30022 A ID30022 A ID 30022A
Authority
ID
Indonesia
Prior art keywords
profilactic
therapy
compounds
formula
cerebral ischemia
Prior art date
Application number
IDW00200101717A
Other languages
English (en)
Indonesian (id)
Inventor
Gerd Steiner
Kurt Schellhaas
Wilfried Lubisch
Uta Holzenkamp
Dorothea Starck
Laszlo Szabo
Franz Emling
Fransisco Javier Garcia Ladona
Hans Peter Hofmann
Liliane Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ID30022A publication Critical patent/ID30022A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW00200101717A 1999-01-11 1999-12-22 Penggunaan senyawa-senyawa dari formula i untuk profilaksis dan terapi pada iskemia serebral ID30022A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19900545A DE19900545A1 (de) 1999-01-11 1999-01-11 Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie

Publications (1)

Publication Number Publication Date
ID30022A true ID30022A (id) 2001-11-01

Family

ID=7893836

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101717A ID30022A (id) 1999-01-11 1999-12-22 Penggunaan senyawa-senyawa dari formula i untuk profilaksis dan terapi pada iskemia serebral

Country Status (24)

Country Link
US (1) US6387912B1 (de)
EP (1) EP1140096A1 (de)
JP (1) JP2002534465A (de)
KR (1) KR20010101442A (de)
CN (1) CN1334732A (de)
AU (1) AU2433800A (de)
BG (1) BG105689A (de)
BR (1) BR9916887A (de)
CA (1) CA2359253A1 (de)
CZ (2) CZ20012484A3 (de)
DE (1) DE19900545A1 (de)
HK (1) HK1042649A1 (de)
HU (1) HUP0201149A3 (de)
ID (1) ID30022A (de)
IL (1) IL144146A0 (de)
MX (1) MXPA01006967A (de)
MY (1) MY133107A (de)
NO (1) NO20013409L (de)
NZ (1) NZ512767A (de)
PL (1) PL348920A1 (de)
SK (1) SK9692001A3 (de)
TR (1) TR200102008T2 (de)
WO (1) WO2000041695A1 (de)
ZA (1) ZA200105475B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900673A1 (de) 1999-01-11 2000-07-13 Basf Ag Verwendung von Bindungspartnern für 5-HT5-Rezeptoren zur Behandlung neurodegenerativer und neuropsychiatrischer Störungen
US6988199B2 (en) * 2000-07-07 2006-01-17 Message Secure Secure and reliable document delivery
JP4548882B2 (ja) * 1999-11-30 2010-09-22 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン化合物
DE10031390A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10031389A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10259382A1 (de) * 2002-12-18 2004-07-01 Abbott Gmbh & Co. Kg 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung
WO2008138126A1 (en) * 2007-05-09 2008-11-20 Neuromed Pharmaceuticals Ltd. Bicyclic pyrimidine derivatives as calcium channel blockers
WO2011024873A1 (ja) * 2009-08-26 2011-03-03 武田薬品工業株式会社 縮合複素環誘導体およびその用途
US11691971B2 (en) 2020-06-19 2023-07-04 Incyte Corporation Naphthyridinone compounds as JAK2 V617F inhibitors
WO2021257863A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Pyrrolotriazine compounds as jak2 v617f inhibitors
US11767323B2 (en) 2020-07-02 2023-09-26 Incyte Corporation Tricyclic pyridone compounds as JAK2 V617F inhibitors
MX2023000056A (es) 2020-07-02 2023-04-12 Incyte Corp Compuestos tricíclicos de urea como inhibidores de la variante v617f de la cinasa de janus 2 (jak2 v617f).
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
TW202302589A (zh) 2021-02-25 2023-01-16 美商英塞特公司 作為ｊａｋ２ ｖ６１７ｆ抑制劑之螺環內醯胺
CA3254582A1 (en) 2022-03-17 2023-09-21 Incyte Corporation TRICYCLIC UREA COMPOUNDS AS JAK2 INHIBITORS V617F

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670560A (en) 1986-04-28 1987-06-02 Ortho Pharmaceutical Corporation Thienopyrimidine-2,4-dione derivatives and intermediates thereof
DE19636769A1 (de) 1996-09-10 1998-03-12 Basf Ag 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE19724980A1 (de) 1997-06-13 1998-12-17 Basf Ag 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE19724979A1 (de) 1997-06-13 1998-12-17 Basf Ag 3-substituierte Pyrido [3,4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
CA2359253A1 (en) 2000-07-20
NO20013409D0 (no) 2001-07-10
HUP0201149A3 (en) 2003-07-28
CZ20012485A3 (cs) 2002-04-17
CZ20012484A3 (cs) 2002-05-15
PL348920A1 (en) 2002-06-17
NO20013409L (no) 2001-08-30
BR9916887A (pt) 2001-11-20
BG105689A (en) 2002-02-28
KR20010101442A (ko) 2001-11-14
MY133107A (en) 2007-10-31
MXPA01006967A (es) 2002-04-10
EP1140096A1 (de) 2001-10-10
NZ512767A (en) 2003-05-30
JP2002534465A (ja) 2002-10-15
ZA200105475B (en) 2002-10-03
DE19900545A1 (de) 2000-07-13
HK1042649A1 (zh) 2002-08-23
CN1334732A (zh) 2002-02-06
TR200102008T2 (tr) 2001-12-21
AU2433800A (en) 2000-08-01
WO2000041695A1 (de) 2000-07-20
SK9692001A3 (en) 2002-05-09
US6387912B1 (en) 2002-05-14
IL144146A0 (en) 2002-05-23
HUP0201149A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
ID30022A (id) Penggunaan senyawa-senyawa dari formula i untuk profilaksis dan terapi pada iskemia serebral
EE200200172A (et) Ühendid isheemia ravimiseks
GB0013378D0 (en) Use of therapeutic benzamide derivatives
NO20021400L (no) Terapeutiske kinazolinderivater
IL163731A0 (en) Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
NO20021329D0 (no) Kinaseinhibitorer som terapeutiske midler
NO20022585D0 (no) Pyrrolidinacetamidderivat alene eller i kombinasjon for behandling av CNS-forstyrrelser
FI971412L (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä
PL356769A1 (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
NO20015112L (no) Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
NO20021845D0 (no) Behandling av sövnforstyrrelser under anvendelse av desloratadin
NO20015227D0 (no) Fremgangsmåte for å öke effektiviteten til anti-cancer midler
IL147891A0 (en) Topical use of anti-muscarnic agents
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
AU2073502A (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
IS6172A (is) Notkun melatoníns til lækninga
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
GB0312566D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
NO20013795D0 (no) Regulering av anestesi
ID30381A (id) Penggunaan arilalkanoilpiridazina
ID29549A (id) Penggunaan turunan-turunan pirimidina untuk profilaksis dan terapi pada iskemia serebral
HUP0303754A3 (en) Use of radical scavenging compounds for preparation of pharmaceutical compsoition suitable for treatment and prevention of no-dependent microcirculation disorders
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
FI991138A0 (fi) Normobarisen hypoksian käyttö terapeuttisesti